AWHL
Aspira Women's Health Inc.Company Information
- Company Name
- Aspira Women's Health Inc.
- CIK
- CIK0000926617
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- AWHL: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2835
- SIC Description
- In Vitro & In Vivo Diagnostic Substances
- Ticker
- AWHL
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-05
- Last sale
- 2023-12-06
- Shares purchased (TTM)
- 1,477,223
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 33
- Shares outstanding
- 34,102,760
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -11.76%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 1 | 2 | 4 | 2 | 3 | 2 | 2 | 1 | 3 | 3 | 5 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 3 | 4 | 4 | 6 | 4 | 5 | 4 | 4 | 3 | 6 | 5 | 8 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Finance Lease Right Of Use Asset | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 4 | 5 | 5 | 7 | 5 | 7 | 5 | 5 | 5 | 7 | 6 | 9 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 2 | 1 | 2 | 2 | 1 | 2 | 3 | 2 | 2 | 1 | 1 | ||||||
| Accrued Liabilities Current | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Long Term Debt Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Borrowings | 1 | 2 | 0 | - | 0 | 0 | 1 | - | 0 | 0 | 1 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 5 | 6 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Long Term Debt Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Warrants And Rights Outstanding | - | - | - | - | - | - | 0 | 0 | 1 | 1 | 2 | 3 | ||||||
| Finance Lease Liability Noncurrent | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 12 | 11 | 12 | 12 | 8 | 7 | 8 | 7 | 8 | 9 | 9 | 9 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity Note | ||||||||||||||||||
| Additional Paid In Capital Common Stock | 539 | 537 | 537 | 536 | 533 | 533 | 529 | 527 | 523 | 522 | 516 | 515 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | -536 | -533 | -531 | -530 | - | - | -518 | - | ||||||
| Retained Earnings Accumulated Deficit | -546 | -544 | -544 | -541 | - | - | -531 | - | -526 | -523 | -518 | -515 | ||||||
| Stockholders Equity | -7 | -6 | -7 | -4 | -3 | -0 | -3 | -3 | -4 | -1 | -2 | -1 | ||||||
| Liabilities And Stockholders Equity | 4 | 5 | 5 | 7 | 5 | 7 | 5 | 5 | 4 | 7 | 6 | 9 | ||||||
| Allowance For Doubtful Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | - | - | 5 | - | - | - | - | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 47 | 44 | 43 | 43 | 36 | 35 | 17 | 16 | 13 | 12 | 11 | 10 | ||||||
| Shares Outstanding | 47 | 44 | 43 | 43 | 36 | 35 | 17 | 16 | 13 | 12 | 11 | 10 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAspira Women's Health Inc. (AWHL) — SEC Financial Statements & Analysis
Aspira Women's Health Inc. (AWHL) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Aspira Women's Health Inc. trades on OTC as: AWHL. Aspira Women's Health Inc. (AWHL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Aspira Women's Health Inc. carries a market cap of $18.14M, a P/E ratio of -1.81x, a P/B ratio of -2.50x, a P/S ratio of 2.12x, an enterprise value of $19.41M, and an EV/EBITDA multiple of -2.88x. On profitability, it posts a gross margin of 58.78%, an operating margin of -80.75%, a net margin of -117.07%, a Return on Equity (ROE) of 201.29%, and a Return on Assets (ROA) of -213.58%. Per share, it reports EPS of $-0.23, diluted EPS of $-0.23, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -8.00% year-over-year, net income growth of 5.83% year-over-year, and EPS growth of -14.94% year-over-year. On the balance sheet, it maintains a current ratio of 0.52x, a quick ratio of 0.37x, working capital of $-2.54M, a debt-to-equity ratio of -1.61x, a debt ratio of 2.64, an interest coverage ratio of -14.62x, free cash flow of $-4.73M (TTM), and net debt of $1.27M. Figures sourced from SEC EDGAR.
- Market Cap
- $18.14M
- P/E TTM
- -1.81x
- EPS TTM
- $-0.23
- P/B TTM
- -2.50x
- ROE TTM
- 201.29%
- ROA TTM
- -213.58%
- Debt To Equity
- -1.61x
- Free Cash Flow TTM
- $-4.73M
- Net Revenue TTM Growth 1Y
- -8.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Aspira Women's Health Inc. in?
Aspira Women's Health Inc. (AWHL) operates in the In Vitro & In Vivo Diagnostic Substances industry.
What exchange does AWHL trade on?
Aspira Women's Health Inc. (AWHL) trades on the OTC.
Where is Aspira Women's Health Inc. incorporated?
Aspira Women's Health Inc. is incorporated in DE.
When was Aspira Women's Health Inc. (AWHL)'s most recent SEC filing?
Aspira Women's Health Inc. (AWHL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is AWHL's market cap?
Aspira Women's Health Inc. (AWHL) has a market capitalization of $18.14M as of 2026-06-30.
What is AWHL's EPS (earnings per share)?
Aspira Women's Health Inc. (AWHL)'s trailing twelve month EPS is $-0.23 as of 2026-06-30.
What is AWHL's ROE (return on equity)?
Aspira Women's Health Inc. (AWHL)'s trailing twelve month Return on Equity (ROE) is 201.29% as of 2026-06-30.
What is AWHL's ROA (return on assets)?
Aspira Women's Health Inc. (AWHL)'s trailing twelve month Return on Assets (ROA) is -213.58% as of 2026-06-30.
What is AWHL's EV/EBITDA?
Aspira Women's Health Inc. (AWHL)'s trailing twelve month EV/EBITDA is -2.88x as of 2026-06-30.